Journal list menu
Alzheimer's & Dementia
Editor-in-Chief: Donna M. Wilcock, PhD
Alzheimer's & Dementia® journal aims to bridge the knowledge gaps across a wide range of bench-to-bedside investigation in dementia and Alzheimer's Disease.
Announcement
We are pleased to announce that Alzheimer’s & Dementia® will join Wiley’s Open Access portfolio as of January 1, 2024. As a result, all submissions received from July 25, 2023 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). For more information on the fees, please click here: Alzheimer's & Dementia Open Access.
Article featured in the September issue of Alzheimer’s & Dementia:
- Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization
- Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set
- Increased oligomeric TDP-43 in the plasma of Korean frontotemporal dementia patients with semantic dementia
- Prevalence of suspected dementia in a sample of adults living in Kinshasa-Democratic Republic of the Congo
- Global rural health disparities in Alzheimer's disease and related dementias: State of the science
Article featured in the October issue of Alzheimer’s & Dementia:
- Pathways explaining racial/ethnic disparities in incident all-cause dementia among middle-aged US adults
- The association of perceived discrimination with dementia risk in Black older adults
- Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals
- Associations between dietary patterns and dementia-related neuroimaging markers
- Sex differences in associations between APOE ε2 and longitudinal cognitive decline
Article featured in the November issue of Alzheimer’s & Dementia:
- Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
- The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology
- Total sleep duration and daytime napping in relation to dementia detection risk: Results from the Million Women Study
- Frontotemporal dementia: Past, present, and future
- Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease
Articles
Prevalence of idiopathic normal pressure hydrocephalus in older adult population in Shanghai, China: A population‐based observational study
- 14 February 2025
Response to the letter titled reply to “Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US”
- 14 February 2025
Reply to “Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US”
- 14 February 2025
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- 535-562
- 1 April 2018
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 263-269
- 22 April 2011
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 270-279
- 22 April 2011
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
- Alzheimer's & Dementia
- 5143-5169
- 27 June 2024
2023 Alzheimer's disease facts and figures
- Alzheimer's & Dementia
- 1598-1695
- 14 March 2023
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US
- Alzheimer's & Dementia
- 8661-8672
- 24 October 2024
Altmetric measures the online attention that an article receives. Click here to view the latest trending articles from Alzheimer’s & Dementia based on attention in the past week.
The list below shows the top 3 Alzheimer’s & Dementia articles based on all-time Altmetric scores:
Recent issues
Volume 21, Issue 2February 2025
Volume 21, Issue 1January 2025
Latest news
Stay Connected with the Alzheimer’s Association®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
Sign up for email alerts
Published on behalf of the
Search articles from all three publications, and keep up with the latest information on the Alzheimer's Association® journal hub page.
Go to the society hub >>
Companion Journals
Virtual Issues
- Virtual Issue: World Wide FINGERS Publications
- Virtual Issue: Research advances in sporadic EOAD
- Special Topic Issue: Psychosocial Measures
Calls for Papers
- Call for Papers: Neuromodulatory Subcortical Systems in Alzheimer's Disease
- Call for Papers: Highlighting TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) Centers
- Call for Papers: Novel Insights into Alzheimer’s Disease through the Study of Individuals with Down Syndrome
- Call for Papers: Advancing Dementia Care and Caregiving Science in Alzheimer’s Disease and Related Dementias
- Call for Papers: Special Issue in Alzheimer’s & Dementia Highlighting New Opportunities for The Therapeutic Targeting of Tauopathy
- Call for Papers: Special Issue in Alzheimer's & Dementia Celebrating the 40th Anniversary of the Alzheimer's Disease Research Centers Program and the 25th Anniversary of the National Alzheimer's Coordinating Centre
- Call for Papers: Global Spotlight Series: Dementia Research in Africa
- DADM Call for Papers: Special Topic Issue - Ethics and equity in implementing novel biomarkers for Alzheimer’s Disease and Related Dementias (ADRD)
- DADM Call for Papers: Addressing Dementia-Related Stigma: Global Perspectives, Challenges, and Inclusive Solutions
- TRCI Call for Papers: Physical Activity and Exercise
- TRCI Call for Papers: Precision Medicine
- TRCI Call for Papers: Special issue topic - Minimal Clinically Important Difference Special Issue
- TRCI Call for Papers: Special Topic Issue - Key Issues in Measurement
- TRCI Call for Papers: The Practice of Inclusion Science - Reimagining and Retooling Approaches to Diversity, Health Equity, and Inclusion
Facts and Figures: 2024
Read the 2024 Alzheimer's disease facts and figures here.
ALZHEIMER'S DRUG DEVELOPMENT & FUNDING
- Read the 2024 Alzheimer's Disease Drug Development Pipeline here.
- View the infographic here.
- Who Funds Alzheimer’s Disease Drug Development?
Stay Connected with the Alzheimer's Association ®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
